Editorial Team

Editorial board

  1. Said Afqir, Medical School, University Mohamed First, Oujda, Morocco
  2. Tzi NG Bun, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong,Shatin, Hong Kong
  3. Pierre Busson, CNRS/Gustave Roussy, Villejuif, France
  4. Jimmy Yu-Wai Chan, University of Hong Kong, China
  5. Mu-Kuan Chen, Changhua Christian Hospital, Taiwan, Province of China
  6. Nian-Yong Chen, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
  7. Shih-Shun Chen, Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan, Province of China
  8. Xiao-Zhong Chen, Zhejiang Cancer Hospital, China
  9. Mu-Hua Cheng, The Third affiliated hospital of Sun Yat-sen university, Guangzhou, Guangdong, China
  10. William Chishing Cho, Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
  11. Balram Chowbay, Laboratory of Clinical Pharmacology, Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre; Office of Clinical Sciences, Duke–NUS Graduate Medical School; The Academia, SingHealth, SingHealth Clinical Pharmacology Core; Singapore
  12. Francois X. Claret, MD Anderson Cancer Center, University of Texas, United States
  13. Patrizia Comoli, Fondazione IRCCS Policlinico San Matteo, Italy
  14. Yan-Fei Deng, Department of Otolaryngology-Head and Neck Surgery, Zhongshan Hospital, Xiamen University, Xiamen, Fujian, China
  15. Zhen-Qing Feng, Nanjing Medical University, Nanjing, Jiangsu, China
  16. Alfio Ferlito, ENT Clinic, University of Udine, Udine, Italy
  17. Stephen Gottschalk, Baylor College of Medicine, Houston, Texas, United States
  18. Xin-Yuan Guan, Deaprtment of Clinical Oncology, The University of Hong Kong, Hong Kong
  19. Nabil Ismaili, Oncologue Medical, CHU Mohammed VI, Marrakech, Maroc
  20. Dai Iwakiti, Institute for Genetic Medicine, Hokkaido University, Japan
  21. Xue-Mei Ji, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
  22. Wei-Hua Jia, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
  23. Alberto Mendoza Espinoza José, Univ Autonoma Ciudad Mexico, Mexico
  24. Jin-Yi Lang, Sichuan Cancer Hospital and Institute, China
  25. Ching-Chih Lee, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, Province of China
  26. Chuan-Xing Li, Sun Yat-sen University Cancer Center, China
  27. Jiang Li, Sun Yat-sen University Cancer Center, China
  28. Jiang-Hua Li, Shenzhen Institute of Information Technology, Shenzhen, Guangdong, China
  29. Jin-Gao Li, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China
  30. Li Li, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
  31. Qing-Lin Li, Anhui Univiersity of Chinese Medicine, Hefei, Anhui, China
  32. Xin Li, Southern Medical University, China
  33. Yi-Zhuo Li, Imaging Diagnosis and Interventional Center, State Key Laboratory of Oncology in Southern China; Sun Yat-sen University Cancer Center, China
  34. Zhi Li, Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
  35. Wan-Teck Lim, Division of Medical Oncology, National Cancer Centre Singapore; Clinical Sciences, Duke-NUS Graduate Medical School, Singapore
  36. Hai-Dan Liu, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
  37. Jun Liu, Department of Neurology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
  38. Tian-Run Liu, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
  39. Zhen Liu, Guangzhou Medical University, China
  40. Hai-Qiang Mai, Sun Yat-sen University Cancer Center, China
  41. Olivier Morales, CNRS UMR 8161, Immunoregulation des cancers viro-induits, Institut de Biologie de Lille, Institut Pasteur de Lille,?Université Lille Nord de France, France
  42. Ester Orlandi, Radiotherapy Unit 2, IRCCS Istituto Nazionale Tumori , Via venezian 1, Milan, Italy
  43. Gokhan Ozyigit, Hacettepe University, Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey
  44. Prabhakar Ramachandran, Peter MacCallum Cancer Centre, Australia
  45. Cai-Ping Ren, Cancer Research Institute, Central South University, Changsha, Hunan, China
  46. Heng Fong Seow, Universiti Putra Malaysia, Korea
  47. An-Kui Yang, Department of Head and Neck Surgery, State Key Laboratory of Oncology in Southern China; Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
  48. Danai Tiwawech, National Cancer Institute, Bangkok, Thailand
  49. Chuan-Miao Xie, Sun Yat-sen University Cancer Center, China
  50. Chuan-Shan Xu, The Chinese University of Hong Kong, Hong Kong
  51. Yowling Shiue, Institute of Biomedical Science, National Sun Yat-sen University, Kaohsiung, Taiwan, Province of China
  52. Guo-Lin Tan, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
  53. Wen-Hung Wang, Department of Otolaryngology-Head and Neck Surgery, Cathay General Hospital and Fu-Jen Catholic University School of Medicine, New Taipei City, Taiwan, Province of China
  54. Wei-Ping Wen, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
  55. Hong-Gyun Wu, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
  56. Jing-Bo Wu, Department of Oncology,Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan, China
  57. Shi-Xiu Wu, Cancer Hospital of Hangzhou, Hangzhou, Zhejiang, China
  58. He Xia, Jiangsu Cancer Hospital, Najing, Jiangsu, China
  59. Yun-Fei Xia, Sun Yat-sen University Cancer Center, China
  60. Zhi-Qiang Xiao, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, Hunan, China
  61. Hironori Yoshiyama, Department of Microbiology, Shimane University Faculty of Medicine, Japan
  62. Lawrence S. Young, University of Warwick, University House, United Kingdom
  63. Jing-Ping Yun, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
  64. Yi Zeng, National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention; College of Life Sciences and Bioengineering, Beijing University of Technology, China
  65. Xiang-Ning Zhang, Guangdong Medical College, Dongguan, Guangdong, China
  66. Zhang Zhe, Department of Otolaryngology-Head & Neck Surgery, First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China
  67. Shao-Bing Zhou, Southwest Jiaotong University, Chengdu, Sichuan, China
  68. Xiao-Dong Zhu, Cancer Hospital of Guangxi Medical University, China

Editor in chief

  1. William Chishing Cho, Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
  2. Yi Zeng, National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention; College of Life Sciences and Bioengineering, Beijing University of Technology, China

Founding Editor

  1. Moly Lee, Journal of Nasopharyngeal Carcinoma Editorial Office, Hong Kong

Reviews Editor

  1. Lian Li, Journal of Nasopharyngeal Carcinoma Editorial Office, Hong Kong

Managing Editor

  1. Ying Huang, Journal of Nasopharyngeal Carcinoma Editorial Office, United States
  2. Yu Lin, Asia Press, Hong Kong

News and Views Editor

  1. Xiaofei Mao, Asia Press, Hong Kong